Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RespireRx Pharmaceuticals Inc.

www.respirerx.com

Latest From RespireRx Pharmaceuticals Inc.

Waking Up Market To US Obstructive Sleep Apnea Epidemic

RespireRx president & CEO James Manuso explained to Scrip during the 2018 Biotech Showcase how the company is repurposing an existing drug to tackle the problem of sleep apnea.

Clinical Trials Companies

Phase III Data Boost Prospects For Jazz's Sleep Apnea Drug

Data from two studies in obstructive sleep apnea suggest drug may hold its own against approved generics, analysts say.

Clinical Trials Research & Development

Pipeline Watch: Phase III Starts For CCX168, ETC-1002 And COR-003

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Research & Development Pipeline Watch

AZ Is Top Deal-Maker: Neurodegenerative Disease Deals, 2010 – Q1 2013

Between 2010 and the first quarter of 2013, biopharma engaged in 70 deals involving neurodegenerative disease assets covering a wide variety of targets – possibly a consequence of uncertainty about the underlying pathophysiology. AstraZeneca was the top deal maker in the field even as it moved away from CNS as a core therapeutic area.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Cortex Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • RespireRx Pharmaceuticals Inc.
  • Senior Management
  • James S Manuso, Pres. & CEO
    Robert N Weingarten, VP, CFO
    Arnold S Lippa, PhD, CSO
    Richard Purcell, SVP, R&D
  • Contact Info
  • RespireRx Pharmaceuticals Inc.
    Phone: (917) 834-7206
    126 Valley Rd., St .
    Glen Rock, NJ 07452
    USA
UsernamePublicRestriction

Register